Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134062) titled 'A Spatiotemporal Gene Expression and Cell Atlas of Fetal Heart Development' on Oct. 10.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Congenital Heart Disease (CHD)
Intervention:
Normal fetal control group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-15
Target Sample Size: Normal fetal control group:30;Fetal congenital heart disease group (including induced abortion fetuses):30;
Countries of Recruitment:
China
To know more, visit http...